Delivery Order SPE2DB20D3103-SPE2DB25FM4T8
Award Date
1/27/25
Potential Completion Date
1/28/25
Potential Value
$26K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB20D3505|SPE2DB25FU0S4, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The award, valued at $1,277.15, is for the delivery of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of February 26, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established...
This federal contract award, with ID SPE2DB22D2206|SPE2DB25FFG12, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4567050166 units of the pharmaceutical product BUDESONIDE-FORMOTEROL 160-4.5 10.2GM. The contract has a firm-fixed price of $10,219.34 and an ultimate completion date of January 27, 2025. The contract is a delivery order and does not have a set-aside designation, indicating open competition....
This federal contract award, with ID SPE2DB20D3505|SPE2DB25FT7M5, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, a pharmaceutical product, and has a firm fixed price ceiling value of $1,350.69. The contract has a completion date of January 7, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract...
The federal contract award, with ID SPE2DB20D3505 and SPE2DB25FT8Z8, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp. The $2,825.45 firm fixed-price delivery order is for the supply of 4567090879 - BUDESONIDE-FORMOTEROL 80-4.5 10.2GM, with a completion date of January 30, 2025. This award is not associated with a set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,347.80, is a delivery order for the supply of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM. The contract has a firm fixed price and an ultimate completion date of April 7, 2025. This award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime...
This federal contract award is for the delivery of the pharmaceutical product "BUDESONIDE-FORMOTEROL 160-4.5 10.2GM" to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $33,634.95 and an ultimate completion date of September 18, 2023. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider registered in the System for Award Management (SAM.gov). This contract is a delivery order...
This federal contract award, valued at $2,040.08, was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract involves the delivery of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, a pharmaceutical product, with a completion date of November 1, 2024. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the delivery of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, a pharmaceutical product, with a ceiling value of $1,897.74. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and the ultimate completion date is September 5, 2024. This contract award is not associated with a set-aside program. AmerisourceBergen Drug Corporation, a major supplier of pharmaceutical...
This federal contract award, valued at $3,006.47, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, a pharmaceutical product, with a completion date of January 3, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs, particularly within military...
This federal contract award, with an ID of SPE2DB20D2002|SPE2DB22FL64S, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $1,696.68 firm fixed-price delivery order is for the supply of 4558190135 - BUDESONIDE-FORMOTEROL 80-4.5 10.2GM, a pharmaceutical product. The contract has an ultimate completion date of August 23, 2022 and was awarded on August 22, 2022. There is no set-aside designation indicated for this contract. Amerisourcebergen...